These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30189174)

  • 21. Refractory Ulcerated Necrobiosis Lipoidica: Closure of a Difficult Wound with Topical Tacrolimus.
    Ginocchio L; Draghi L; Darvishian F; Ross FL
    Adv Skin Wound Care; 2017 Oct; 30(10):469-472. PubMed ID: 28914682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ulcerative necrobiosis lipoidica successfully treated with photodynamic therapy: case report and literature review.
    Borgia F; Vaccaro M; Cantavenera LG; Aragona E; Cannavò SP
    Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):516-8. PubMed ID: 25150669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Necrobiosis lipoidica: treatment by hyperbaric oxygen and local corticosteroids.
    Bouhanick B; Verret JL; Gouello JP; Berrut G; Marre M
    Diabetes Metab; 1998 Apr; 24(2):156-9. PubMed ID: 9592641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term successful healing of ulcerated necrobiosis lipoidica after topical therapy with becaplermin.
    Tauveron V; Rosen A; Khashoggi M; Abdallah-Lotf M; Machet L
    Clin Exp Dermatol; 2013 Oct; 38(7):745-7. PubMed ID: 23962308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Necrobiosis lipoidica: a descriptive study of 35 cases.
    Marcoval J; Gómez-Armayones S; Valentí-Medina F; Bonfill-Ortí M; Martínez-Molina L
    Actas Dermosifiliogr; 2015 Jun; 106(5):402-7. PubMed ID: 25728565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic causes of leg ulcers.
    McGoey JW
    Clin Dermatol; 1990; 8(3-4):86-91. PubMed ID: 2129953
    [No Abstract]   [Full Text] [Related]  

  • 27. Squamous cell carcinoma developing in necrobiosis lipoidica.
    Imtiaz KE; Khaleeli AA
    Diabet Med; 2001 Apr; 18(4):325-8. PubMed ID: 11437865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ulceration in necrobiosis lipoidica--a case report and study.
    Dwyer CM; Dick D
    Clin Exp Dermatol; 1993 Jul; 18(4):366-9. PubMed ID: 8403479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in Ulcerative Necrobiosis Lipoidica After Janus Kinase-Inhibitor Therapy for Polycythemia Vera.
    Lee JJ; English JC
    JAMA Dermatol; 2018 Jun; 154(6):733-734. PubMed ID: 29800055
    [No Abstract]   [Full Text] [Related]  

  • 30. Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin.
    Darvay A; Acland KM; Russell-Jones R
    Br J Dermatol; 1999 Oct; 141(4):725-7. PubMed ID: 10583126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid healing of ulcerated necrobiosis lipoidica with optimum glycaemic control and seaweed-based dressings.
    Rowe BR; Bain SC; Pizzey M; Barnett AH
    Br J Dermatol; 1991 Dec; 125(6):603-4. PubMed ID: 1760369
    [No Abstract]   [Full Text] [Related]  

  • 32. Healing of chronic leg ulcers in diabetic necrobiosis lipoidica with local granulocyte-macrophage colony stimulating factor treatment.
    Remes K; Rönnemaa T
    J Diabetes Complications; 1999; 13(2):115-8. PubMed ID: 10432176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Squamous cell carcinoma arising in an area of long-standing necrobiosis lipoidica.
    Lim C; Tschuchnigg M; Lim J
    J Cutan Pathol; 2006 Aug; 33(8):581-3. PubMed ID: 16919034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Necrobiosis Lipoidica in a Patient with β-Thalassemia Major: A Case Report and Review of the Literature.
    Vetsiou E; Mpouras V; Nikolaidou C; Klonizakis P; Mandala E; Vamvakis K; Psarras K; Vlachaki E
    Hemoglobin; 2020 May; 44(3):221-223. PubMed ID: 32605400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Necrobiosis Lipoidica.
    Sibbald C; Reid S; Alavi A
    Dermatol Clin; 2015 Jul; 33(3):343-60. PubMed ID: 26143418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarcoidosis with leg ulcers and annular facial lesions.
    Saxe N; Benatar SR; Bok L; Gordon W
    Arch Dermatol; 1984 Jan; 120(1):93-6. PubMed ID: 6691720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on clinical and laboratory features in necrobiosis lipoidica: a retrospective multicentre study of 52 patients.
    Erfurt-Berge C; Seitz AT; Rehse C; Wollina U; Schwede K; Renner R
    Eur J Dermatol; 2012; 22(6):770-5. PubMed ID: 23114030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infliximab: a promising new treatment option for ulcerated necrobiosis lipoidica.
    Kolde G; Muche JM; Schulze P; Fischer P; Lichey J
    Dermatology; 2003; 206(2):180-1. PubMed ID: 12592093
    [No Abstract]   [Full Text] [Related]  

  • 39. Cofactors and comorbidities of necrobiosis lipoidica: analysis of the German DRG data from 2012.
    Jockenhöfer F; Kröger K; Klode J; Renner R; Erfurt-Berge C; Dissemond J
    J Dtsch Dermatol Ges; 2016 Mar; 14(3):277-84. PubMed ID: 26972191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-diabetic necrobiosis lipoidica. Hitherto unrecognized papulonecrotic, nodulo-ulcerative and familial forms of the disease.
    Findlay GH; Morrison JG; de Beer HA
    S Afr Med J; 1981 Mar; 59(10):323-6. PubMed ID: 7466484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.